Covid-19’da Nörolojik Tutulum
Özet
SARS-CoV-2 kaynaklı COVID-19, başlangıçta solunum yolu hastalığı olarak tanımlansa da multisistemik etkileriyle beyin dahil pek çok organı tutabilmektedir. Çocuklarda yetişkinlere kıyasla daha nadir ve hafif seyretse de hastalık tat kaybı, baş ağrısı, ensefalopati ve nadiren inme gibi nörolojik komplikasyonlara yol açabilmektedir. Patogenezde viral invazyon, inflamatuar sitokin fırtınası ve endotel hasarı gibi faktörler rol oynarken, kronik nörolojik rahatsızlığı olan çocuklar daha yüksek risk altındadır. Bu nedenle, özellikle ağır seyreden vakalarda nörolojik belirtilerin yakından izlenmesi ve uygun klinik tedavinin uygulanması büyük önem taşımaktadır.
Although initially characterized as a respiratory disease, COVID-19 can affect multiple systems, including the brain, due to its multisystemic nature. While neurological complications in children are rarer and generally milder than in adults, they can manifest as symptoms such as headaches, loss of taste, encephalopathy, and occasionally strokes. The underlying mechanisms—including direct viral invasion, cytokine storms, and endothelial damage—pose higher risks for children with pre-existing chronic neurological conditions. Consequently, careful monitoring of neurological signs is essential for managing severe cases and mitigating potential impacts.
Referanslar
Kovid19 haritası. Çevrimiçi olarak erişilebilir: https://coronavirus.jhu.edu/map.html (01.06.2021)
Children and COVID-19: State Data Report. A joint report from the American Academy of Pediatrics and the Children’s Hospital Association, Summary of publicly reported data from 49 states, NYC, DC, PR, and GU. Version: 5/27/21
Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID-19: A multisystem disease? J Med Virol. 2021;93:323–335.
Al-Ramadan A, Rabab’h O, Shah J, Gharaibeh A. Acute and Post-Acute Neurological Complications of COVID-19. Int. 2021, 13, 102–119.
Mishra R, Banerjea AC. Neurological Damage by Coronaviruses: A Catastrophe in the
Queue!. Front. Immunol. 11:565521. doi: 10.3389/fimmu.2020.565521
Gheblawi M, Wang K, Viveiros A, Nguyen Q, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System.Circulation Research. 2020;126:1457–1475.
Gupta A, Madhavan MV, Sehgal K, Nair N et al. Extrapulmonary manifestations of COVID-19. Nature Medicine.2020;10: 1017–1032
Ariane Lewis A, Frontera J, Placantonakis DG, Lighter J. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci. 2021 Feb 15;421:117316. doi: 10.1016/j.jns.2021.117316.
Balcioglu YH, Yesilkaya UM, Gokcay H, Kirlioglu SS. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal. J Neuroimmune Pharmacol. 2020 Jun 11 : 1–2. doi: 10.1007/s11481-020-09932-9 [Epub ahead of print]
Kim Y, PhD1 , Walser SA, Asghar SJ, Jain R, Mainali G, Kumar A. A Comprehensive Review of Neurologic Manifestations of COVID-19 and Management of Pre-existing Neurologic Disorders in Children. Journal of Child Neurology 2021;36:324-330
Mantovani A, Rinaldi E, Zusi C, Beatrice G,Saccomani MD, Dalbeni A. Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis. Pediatric Research.2021; 89:733 – 737
Pousa PA, Mendonc TSC, Oliveira EA, Silva ACS. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations. Jornal de Pediatria 97. 2021; 116-139
Vivanti AJ, Vauloup-Fellous C, Prevot S, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11(1):1-7.
McAbee GN, Brosgol Y, Pavlakis S, Agha R, Gaffoor M. Encephalitis associated with COVID-19 infection in an 11 year-old child. Pediatr Neurol. 2020;109:94.
Rodriguez CB, Toledo JS, Clark BC, Herberg J. et al. Multisystem Inflammatory Syndrome in Children: An International Survey. Pediatrics February 2021, 147 (2) e2020024554; DOI: https://doi.org/10.1542/peds.2020-024554
Tai-Heng Chena. Neurological involvement associated with COVID-19 infection in children. Letter to the Editor. Journal of the Neurological Sciences 418 (2020) 117096
Duarte-Netoa AN, Caldinia EG, Gomes-Gouv^eac MS, Kanamurab CT et al. An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C. EClinicalMedicine 35 (2021) 100850
Manzo ML, Galati C, Gallo C, Santangelo G et al. ADEM post-Sars-CoV-2 infection in a pediatric patient with Fisher-Evans syndrome. Neurological Sciences https://doi.org/10.1007/s10072-021-05311-1
Henriques-Souza AMM1, Melo ACM, Silva Madeiro BAC, Freitas LF, Rocha-Filho PAS, Gonçalves FG. Acute disseminated encephalomyelitis in a COVID-19 pediatric patient. Neuroradiology. https://doi.org/10.1007/s00234-020-02571-0
Akçay N, Menentoğlu ME, Bektaş G, Şevketoğlu E. Axonal Guillain‐Barre syndrome associated withSARS‐CoV‐2 infection in a child. J Med Virol. 2021;1–4.
Lazarte-Rantes C, Guevara-Castañón J, Romero L, Guillén-Pinto D. Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient. Cureus 13(5): e15018. DOI 10.7759/cureus.15018
LaRovere KL, Riggs BJ, Poussaint TY, Young CCet al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;78(5):536-547. doi:10.1001/jamaneurol.2021.0504
Abdel-Mannan O, Eyre M, Löbel U, Bamford A, et al. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. JAMA Neurol. 2020;77(11):1440-1445. doi:10.1001/jamaneurol.2020.2687
https://www.uptodate.com/contents/covid-19-management-in-children
https://www.covid19treatmentguidelines.nih.gov/special-populations/children/
T.C. Sağlık Bakanlığı Halk Sağlığı Genel müdürlüğü, covıd-19 (sars-cov-2 enfeksiyonu) çocuk hasta yönetimi ve tedavi. Bilimsel Danışma Kurulu Çalışması. 20 Mayıs 2021
Ellul MA, Benjamin L, Singh B, Lant S, et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19: 767–83
Padda I, Khehra N, Jaferi U , Parmar MS, et al. The Neurological Complexities and Prognosis of COVID-19. SN Compr Clin Med. 2020 Sep 29;1-12. doi: 10.1007/s42399-020-00527-2.
Emamikhah M, Babadi M, Mehrabani M, Jalili M, Pouranian M, Daraie P, Mohaghegh F, Aghavali S, Zaribafian M, Rohani M. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol. 2021 Feb;27(1):26-34. doi: 10.1007/s13365-020-00941-1.
Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Kruer MC. Opsoclonus-myoclonus-ataxia syndrome in children. J Neurol. 2022 Feb;269(2):750-757. doi: 10.1007/s00415-021-10536-3.
